文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肿瘤-间质比与肿瘤芽生的联合模型与口腔鳞状细胞癌患者的肿瘤复发或转移无关。

Combined Model of Tumor-Stroma Ratio and Tumor Budding Are Not Associated with Tumor Recurrence or Metastasis in Oral Squamous Cell Carcinoma Patients.

作者信息

Boščić Drago, Dragaš Emili, Košec Andro, Geber Goran, Tomasović-Lončarić Čedna, Vagić Davor

机构信息

Department of Otorhinolaryngology, University Hospital Dubrava, Avenija Gojka Šuška 6, 10000 Zagreb, Croatia.

School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.

出版信息

Diagnostics (Basel). 2025 Jul 22;15(15):1844. doi: 10.3390/diagnostics15151844.


DOI:10.3390/diagnostics15151844
PMID:40804808
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12346568/
Abstract

Histopathological grading of oral squamous cell carcinoma is currently based on differentiation of cells, while additional histological parameters, such as the tumor-stroma ratio (TSR), tumor budding (TB), or the combined TSR/tumor budding model could better assess tumor biological behavior and monitoring of patients. : To integrate risk factors associated with tumor progression: the TSR, TB and TSR/tumor budding model, whose prognostic significance in oral cancer has not yet been evaluated. : An observational cohort retrospective study assembled according to STROBE guidelines on histological materials from 196 patients with invasive squamous cell carcinoma of the oral cavity. The goal of the analysis was to evaluate the association between the tumor stroma ratio, tumor budding, and the combined model of TSR/TB with the clinical and pathologic features of patients with squamous cell carcinoma of the oral cavity and to determine the prognostic value of this model in relation to disease-free survival (DFS) : The analysis did not show that the tumor stroma ratio (TSR), tumor budding, and the combined model of TSR/tumor budding were statistically significantly associated with the occurrence of metastatic disease at the start of treatment or during postoperative follow-up, but confirmed the value of depth-of-invasion (DOI) as a negative prognostic factor (HR 15.3, < 0.001). : The TSR, TB, and the combined TSR/TB model were not found to be statistically significant predictors for the disease progression in the Cox regression survival analysis but were found to have a significant correlation with known negative prognostic factors: DOI, neural invasion, and T category.

摘要

口腔鳞状细胞癌的组织病理学分级目前基于细胞分化,而其他组织学参数,如肿瘤-间质比(TSR)、肿瘤芽生(TB)或联合的TSR/肿瘤芽生模型,可能能更好地评估肿瘤生物学行为并监测患者。:整合与肿瘤进展相关的危险因素:TSR、TB和TSR/肿瘤芽生模型,其在口腔癌中的预后意义尚未得到评估。:根据STROBE指南,对196例口腔浸润性鳞状细胞癌患者的组织学材料进行观察性队列回顾性研究。分析的目的是评估肿瘤间质比、肿瘤芽生以及TSR/TB联合模型与口腔鳞状细胞癌患者临床和病理特征之间的关联,并确定该模型对无病生存期(DFS)的预后价值:分析未显示肿瘤间质比(TSR)、肿瘤芽生以及TSR/肿瘤芽生联合模型与治疗开始时或术后随访期间转移性疾病的发生有统计学显著关联,但证实了浸润深度(DOI)作为阴性预后因素的价值(HR 15.3,<0.001)。:在Cox回归生存分析中,未发现TSR、TB和联合的TSR/TB模型是疾病进展的统计学显著预测因素,但发现它们与已知的阴性预后因素:DOI、神经侵犯和T分类有显著相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/12346568/0465e3799f59/diagnostics-15-01844-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/12346568/40bea185a070/diagnostics-15-01844-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/12346568/29882faebc26/diagnostics-15-01844-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/12346568/2f99b1a78622/diagnostics-15-01844-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/12346568/1797c3028d8c/diagnostics-15-01844-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/12346568/12f8337f3dff/diagnostics-15-01844-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/12346568/868a9044bd32/diagnostics-15-01844-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/12346568/0465e3799f59/diagnostics-15-01844-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/12346568/40bea185a070/diagnostics-15-01844-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/12346568/29882faebc26/diagnostics-15-01844-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/12346568/2f99b1a78622/diagnostics-15-01844-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/12346568/1797c3028d8c/diagnostics-15-01844-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/12346568/12f8337f3dff/diagnostics-15-01844-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/12346568/868a9044bd32/diagnostics-15-01844-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/12346568/0465e3799f59/diagnostics-15-01844-g007.jpg

相似文献

[1]
Combined Model of Tumor-Stroma Ratio and Tumor Budding Are Not Associated with Tumor Recurrence or Metastasis in Oral Squamous Cell Carcinoma Patients.

Diagnostics (Basel). 2025-7-22

[2]
Prognostic Role of Tumor-Infiltrating Lymphocytes, Tumor Budding, Tumor Border Configuration, and Tumor Stroma Ratio in Colorectal Carcinoma.

Indian J Surg Oncol. 2025-4

[3]
Tumor Budding as an Independent Prognostic Histopathological Marker in Oral Squamous Cell Carcinoma - An Indian Tertiary Care Center Experience.

Turk Patoloji Derg. 2025

[4]
Prognostic Value of Tumor-Stroma Ratio in a Screened Stage II Colon Cancer Population: Intratumoral Site-Specific Assessment and Tumor Budding Synergy.

Mod Pathol. 2025-6

[5]
The prognostic significance of desmoplastic reaction, tumor budding and tumor-infiltrating lymphocytes in esophageal squamous cell carcinomas.

BMC Gastroenterol. 2025-7-1

[6]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[7]
Systemic treatments for metastatic cutaneous melanoma.

Cochrane Database Syst Rev. 2018-2-6

[8]
A Study on Cancer-Associated Fibroblast Using Alpha-Smooth Muscle Actin Immunohistochemistry in Oral Squamous Cell Carcinoma.

Cureus. 2025-5-29

[9]
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.

Clin Orthop Relat Res. 2024-12-1

[10]
The Prognostic Role of Tumor-Stroma Ratio in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Asian Pac J Cancer Prev. 2025-7-1

本文引用的文献

[1]
Evaluating Depth of Invasion as a Continuous Prognostic Factor in Oral Squamous Cell Carcinoma.

Head Neck. 2025-3

[2]
Tumor Budding and Poor Prognosis in Oral Cancer: A Systematic Review and Meta-Analysis.

Asian Pac J Cancer Prev. 2023-8-1

[3]
Tumor Budding Should Be in Oral Cavity Cancer Reporting: A Retrospective Cohort Study Based on Tumor Microenvironment.

Cancers (Basel). 2023-8-1

[4]
Evaluation of tumor budding and its correlation with histomorphological prognostic markers in oral squamous cell carcinoma and its association with the epithelial-mesenchymal transition process.

Indian J Pathol Microbiol. 2023

[5]
Worst pattern of invasion in oral squamous cell carcinoma is an independent prognostic factor.

J Oral Biol Craniofac Res. 2022

[6]
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Tumours of the Oral Cavity and Mobile Tongue.

Head Neck Pathol. 2022-3

[7]
Emerging histopathologic markers in early-stage oral tongue cancer: A systematic review and meta-analysis.

Head Neck. 2022-6

[8]
Epithelial-mesenchymal transition and its transcription factors.

Biosci Rep. 2022-1-28

[9]
Dataset for Pathology Reporting of Colorectal Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

Ann Surg. 2022-3-1

[10]
Assessment of Histological Features in Squamous Cell Carcinoma Involving Head and Neck Skin and Mucosa.

J Clin Med. 2021-5-27

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索